A comprehensive review finds CBD shows promise for treating core symptoms and comorbidities of autism through its interaction with the endocannabinoid system, gut-brain axis modulation, and multi-target pharmacological profile, with a favorable safety profile.
Parents of children with ASD, autism researchers, and clinicians exploring cannabinoid therapies.
CBD interacts with the endocannabinoid system, which regulates social behavior and brain development relevant to ASD
What the researchers found
CBD interacts with the endocannabinoid system, which plays crucial roles in social and behavioral processing and neuronal development relevant to ASD. Preliminary clinical trial data indicate CBD may modulate specific ASD symptoms and comorbidities. Emerging evidence suggests CBD may also influence the gut microbiota, relevant to gut-brain communication in ASD.
Why it matters
ASD has very limited effective pharmacological interventions. CBD's multi-target profile and safety record make it a candidate for addressing both core symptoms and the many comorbidities (anxiety, sleep problems, irritability) that significantly affect quality of life for individuals with ASD.
The numbers in context
CBD described as safe with low side effects; multi-target pharmacological profile; evidence from preclinical models and preliminary clinical trials
How the study worked
Review of preclinical and clinical evidence for CBD in ASD, examining endocannabinoid system involvement, clinical trial results, gut microbiome interactions, and safety data.
What this study cannot tell us
Most evidence is preclinical. Clinical trials have been small and preliminary. ASD is highly heterogeneous, making treatment response unpredictable. Long-term safety in developing brains needs more study.
How to read the evidence
Review of mostly preclinical evidence with preliminary clinical findings. Theoretical framework is strong but clinical evidence remains early-stage.
When this study was published
Published in 2024.
The bigger picture
The endocannabinoid system's role in social behavior and brain development provides a theoretical foundation for why CBD might help in ASD. The gut-brain axis connection is a newer and intriguing dimension of this research.
Questions still open
- Which ASD subpopulations are most likely to benefit from CBD?
- Could CBD's gut microbiome effects contribute to behavioral improvements in ASD?
Common questions
Could CBD help with autism?
Is CBD safe for people with autism?
Read the original research
Therapeutic potential of CBD in Autism Spectrum Disorder.
International review of neurobiology, 177, 149-203
Citation
Pedrazzi, João F C; Hassib, Lucas; Ferreira, Frederico R; Hallak, Jaime C; Del-Bel, Elaine; Crippa, José A. (2024). Therapeutic potential of CBD in Autism Spectrum Disorder.. International review of neurobiology, 177, 149-203. https://doi.org/10.1016/bs.irn.2024.05.002
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk